Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms. Shah ED. Aliment Pharmacol Ther 2023;57:1335-1336.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shah ED. Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms. Aliment Pharmacol Ther 2023;57:1335-1336.
PMID: 37161628